What we already know about rhubarb


Autor: Hong Xiang ez al.


Journal: Chinese Medicine volume 15, Article number: 88 (2020), englisch


Rhubarb (also named Rhei or Dahuang), one of the most ancient and important herbs in traditional Chinese medicine (TCM), belongs to the Rheum L. genus from the Polygonaceae family, and its application can be traced back to 270 BC in “Shen Nong Ben Cao Jing”. Rhubarb has long been used as an antibacterial, anti-inflammatory, anti-fibrotic and anticancer medicine in China. However, for a variety of reasons, such as origin, variety and processing methods, there are differences in the effective components of rhubarb, which eventually lead to decreased quality and poor efficacy.

Additionally, although some papers have reviewed the relationship between the active ingredients of rhubarb and pharmacologic actions, most studies have concentrated on one or several aspects, although there has been great progress in rhubarb research in recent years. Therefore, this review aims to summarize recent studies on the geographic distribution, taxonomic identification, pharmacology, clinical applications and safety issues related to rhubarb and provide insights into the further development and application of rhubarb in the future.


Andere Benutzer haben sich neben diesem auch noch folgende Artikel angesehen:

Effects of Acupuncture and Moxibustion on Breast Cancer-Related Lymphedema
Yu Gao et al.; 2021

Efficacy and Safety of Chinese Herbal Medicine on Treatment of Breast Cancer
Venice Wing-Tung Ho et al.; 2021

Traditional application and modern pharmacological research of Eucommia ulmoides Oliv.
Lichuang Huang et al.; 2021




 
 

Vorheriger Artikel

Übersicht

Nächster Artikel
 

Link zum Journal